Development platform
RLI · Regulatory and Labeling Intelligence

Regulatory catalogue

Legislation and guidance that shape the labelling and packaging of human medicines, classified by issuer, legal force, markets and the packaging components they bear on. Each entry links to the publicly accessible source.

PrototypePublic demoFull: Testersv0.1
Demo Showing 12 of 56 documents.

The public demo shows a sample of two documents per region with basic filters and summaries. Sign in or register as a tester for the full catalogue: all documents, search, market / topic / product filters, key requirements, transition notes and CSV export. Prototype content: always check the linked source.

Coverage

Documents by region and legal force

Legal force says how strongly a document binds, from primary legislation (L1) to drafts (P). Select a number to filter.

RegionL1LawL2RuleG1GuidanceG2Template / Q&ASStandardPDraftAll
EU institutionsEuropean Commission, Parliament and Council 1 1 · · · · 2
EMA / HMA networkEuropean Medicines Agency, CMDh and the EU regulatory network · · · 2 · · 2
United StatesCongress, FDA, CPSC · 1 1 · · · 2
ChinaNPC, NMPA, SAMR · 1 · · 1 · 2
JapanDiet, MHLW, PMDA 1 · 1 · · · 2
IndiaParliament, MoHFW, CDSCO, DGFT, NPPA · 2 · · · · 2
What the classifications mean

Legal force

L1Primary legislation
Act, directive or regulation adopted by the legislator. Legally binding (an EU directive binds through national transposition).
L2Implementing legislation
Delegated or implementing act, federal regulation (CFR), ministerial order or gazette notification. Legally binding.
G1Official guidance
Guideline or notification of a competent authority. Not law, but assessors expect it; deviations must be justified.
G2Templates and procedural guidance
Templates, Q&A, procedural and submission guidance of an authority. Practically required to pass the procedure.
SStandard
Technical or information standard (authority or standards body). Voluntary unless legislation refers to it.
PDraft or proposal
Legislative proposal, draft guidance or consultation. Not yet binding; monitor for artwork impact.

Relevance per packaging component

D Direct
Prescribes content, layout or codes printed on this component.
I Indirect
Affects the component through process, approval, coding infrastructure or design expectations.
C Context
Background: frames the requirements but contains none for this component itself.

Components (strip order)

  1. Carton Outer packaging / folding carton
  2. Label Immediate container label (bottle, tube, large vial, bag)
  3. Blister / foil Blisters, strips, sachets, lidding foil
  4. Small unit Small immediate packaging: ampoule, small vial, cartridge, pen
  5. Leaflet Package leaflet / PIL, package insert, prescribing information, Medication Guide
  6. Device Integral or co-packaged device and its instructions for use
  7. Shipper / case Tertiary packaging: shipping case, homogeneous case, pallet
  8. e-Labelling Electronic product information, QR / 2D-code linked content
Greyed-out filters need a tester account.

12 documents

Document Legal force Markets Components Effective Source
RI-EU-001 Community code (Directive 2001/83/EC) European Parliament and Council · Directive 2001/83/EC, OJ L 311, 28.11.2001 L1Law
In force
EU 27, EEA (IS, LI, NO) Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: DirectLeaflet: DirectDevice: ContextShipper / case: not relevante-Labelling: not relevantImpact: high 18 Dec 2001 Official text (opens in a new tab)
RI-EU-002 Safety features (Delegated Regulation 2016/161) European Commission · Delegated Regulation (EU) 2016/161, OJ L 32, 9.2.2016 L2Rule
In force
EU 27, EEA (IS, LI, NO) Carton: DirectLabel: DirectBlister / foil: ContextSmall unit: not relevantLeaflet: not relevantDevice: not relevantShipper / case: Contexte-Labelling: not relevantImpact: high 9 Feb 2019 Official text (opens in a new tab)
RI-EMA-001 QRD templates (human) European Medicines Agency (QRD group) · EMA QRD templates, version 10.x, with QRD convention and Appendices G2Template / Q&A
In force
EU 27, EEA (IS, LI, NO) Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: DirectLeaflet: DirectDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high – Issuer page (document listed there) (opens in a new tab)
RI-EMA-002 Mock-ups and specimens European Medicines Agency · EMA/305821/2006 (current revision) G2Template / Q&A
In force
EU 27, EEA (IS, LI, NO) Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: DirectLeaflet: DirectDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high – Official text (opens in a new tab)
RI-US-002 21 CFR 201 (drug labeling) U.S. Food and Drug Administration · 21 CFR Part 201 L2Rule
In force
United States Carton: DirectLabel: DirectBlister / foil: IndirectSmall unit: DirectLeaflet: DirectDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high – Consolidated text (opens in a new tab)
RI-US-013 Container and carton design guidance U.S. Food and Drug Administration · FDA guidance, May 2022 (final) G1Guidance
In force
United States Carton: DirectLabel: DirectBlister / foil: IndirectSmall unit: DirectLeaflet: not relevantDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high May 2022 Official text (opens in a new tab)
RI-CN-002 Insert and label provisions (SFDA Order 24) State Food and Drug Administration (now NMPA) · SFDA Order No. 24 药品说明书和标签管理规定 L2Rule
In force
China (mainland) Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: DirectLeaflet: DirectDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high 1 Jun 2006 Issuer page (document listed there) (opens in a new tab)
RI-CN-004 Traceability code labelling (NMPAB/T 1011—2022) National Medical Products Administration · NMPAB/T 1011—2022; NMPA Announcement 2022 No. 50 药品追溯码标识规范 SStandard
In force
China (mainland) Carton: DirectLabel: DirectBlister / foil: not relevantSmall unit: IndirectLeaflet: not relevantDevice: not relevantShipper / case: Directe-Labelling: not relevantImpact: high 23 Jun 2023 Official text (opens in a new tab)
RI-JP-001 PMD Act National Diet of Japan · Act No. 145 of 1960 (amended 2019, Act No. 63) 医薬品、医療機器等の品質、有効性及び安全性の確保等に関する法律 L1Law
In force
Japan Carton: DirectLabel: DirectBlister / foil: not relevantSmall unit: DirectLeaflet: DirectDevice: not relevantShipper / case: not relevante-Labelling: DirectImpact: high 10 Aug 1960 Consolidated text (opens in a new tab)
RI-JP-003 Barcode labelling guidelines (Rx) Ministry of Health, Labour and Welfare · MHLW notification of 15 Sep 2006, revised 2012 and 2016 (Iseikei 0830-1 et al.) 医療用医薬品へのバーコード表示の実施要項 G1Guidance
In force
Japan Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: DirectLeaflet: not relevantDevice: not relevantShipper / case: Directe-Labelling: not relevantImpact: high 15 Sep 2006 Official text (opens in a new tab)
RI-IN-002 Drugs Rules 1945, Part IX labelling Ministry of Health and Family Welfare (CDSCO) · Drugs Rules, 1945, Rules 94–106A L2Rule
In force
India (domestic) Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: DirectLeaflet: IndirectDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high 21 Dec 1945 Consolidated text (opens in a new tab)
RI-IN-003 Schedule H2: QR / barcode on top 300 brands Ministry of Health and Family Welfare · G.S.R. 823(E), 17 Nov 2022; CDSCO FAQs of 21 Jul 2023 L2Rule
In force
India (domestic) Carton: DirectLabel: DirectBlister / foil: DirectSmall unit: not relevantLeaflet: not relevantDevice: not relevantShipper / case: not relevante-Labelling: not relevantImpact: high 1 Aug 2023 Authority Q&A / summary (opens in a new tab)

Compiled from the issuers' public websites (status as of the date shown on each entry). Not legal advice and not a validated source: confirm requirements in the official text before regulatory use. Entries marked "verify" contain details not yet checked against the official text.